UNSPSC 51393403: Etofylline

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51393403

Definition

This classification denotes a phosphodiesterase inhibitor with the molecular formula C9H12N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L164909TBI, chemically known as 3,7-dihydro-7-(2-hydroxyethyl)-1,3-dimethyl-1h-purine-2,6-dione (9ci) but generally known as etofylline, which bears US NIH Compound Identifier 1892. European Medicines Agency schedules Etofylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07324MIG.

Read the full definition

The term ETOFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). ETOFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etofylline under HS 29395900 and SITC 54145. As of Q4 2014, ETOFYLLINE remains the US FDA Preferred Term for this commodity. Etofylline bears US NLM identifiers UMLS ID C0059871 and NCI Concept Code C80611. SMILES: O=C1N(C(=O)N(C2NCN(C12)CCO)C)C.

About UNSPSC 51393403

UNSPSC 51393403 Etofylline is a Commodity code that captures pharmaceutical products purchased by state and local health agencies, though recent solicitation activity under this code shows a substantial mismatch between the nominal commodity (etofylline, a respiratory stimulant) and what is actually being procured. State and local governments are buying naloxone (an opioid antagonist) and drug deactivation systems through this code, indicating either miscoding or a broader administrative classification that encompasses emergency medical countermeasures and public health supplies. The solicitations reflect purchases by county health departments and community health programs designed to support harm-reduction and overdose-response initiatives. Vendors typically supply products in bulk quantities (measured in units of hundreds or thousands annually) with delivery to centralized county health facilities.

Seminole County, Florida represents the identifiable recent activity under this code. The county released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The IFB response deadline was July 26, 2023 (note: the posted date of June 30, 2026 does not align with the stated deadline, suggesting potential data inconsistency in the source). Vendors must include shipping and delivery costs in their bids and comply with E-Verify and drug-free workplace certification requirements. The contract structure includes a two-year initial term with a one-year renewal option and a three-month probationary period. The procurement carries no explicit set-aside designation but may draw FEMA funding, which subjects vendors to federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. Recent solicitation activity under this code is limited to the single Seminole County opportunity.

Quick answers

What is UNSPSC 51393403?

UNSPSC 51393403 is Etofylline, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51393403?

UNSPSC 51393403 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51393403

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code